Biocryst Pharmaceuticals (BCRX) Other Non-Current Liabilities (2011 - 2019)
Biocryst Pharmaceuticals' (BCRX) quarterly Other Non-Current Liabilities came in at $3.5 million in Q3 2019, down 5.32% on a QoQ basis from $3.7 million in Q2 2019.
Biocryst Pharmaceuticals (BCRX) Other Non-Current Liabilities (2011 - 2019) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 7 years of Other Non-Current Liabilities data on file, last reported at $3.5 million in Q3 2019.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $3.5 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $3.5 million (changed N/A YoY) and the FY2018 annual result came in at $2.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities retreated to $3.5 million in Q3 2019, from $3.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $3.9 million in Q1 2019 to a low of $974000.0 in Q2 2016.
- A 3-year average of $2.8 million and a median of $3.1 million in 2018 frame the typical range for Other Non-Current Liabilities.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 3.54 Mn |
| Jun 30, 2019 | 3.74 Mn |
| Mar 31, 2019 | 3.89 Mn |
| Dec 31, 2018 | 2.70 Mn |
| Sep 30, 2016 | 1.90 Mn |
| Jun 30, 2016 | 974,000.00 |
| Jun 30, 2014 | 2.81 Mn |
| Mar 31, 2014 | 981,000.00 |
| Sep 30, 2013 | 1.58 Mn |
| Jun 30, 2013 | 1.68 Mn |
| Mar 31, 2013 | 2.79 Mn |
| Dec 31, 2012 | 4.75 Mn |
| Sep 30, 2012 | 5.53 Mn |
| Jun 30, 2012 | 4.96 Mn |
| Mar 31, 2012 | 3.96 Mn |
| Dec 31, 2011 | 4.00 Mn |
| Sep 30, 2011 | 2.93 Mn |
| Jun 30, 2011 | 2.34 Mn |